Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Intangibles (2019 - 2026)

Viatris (VTRS) posted Intangibles of $13.7 billion for Q2 2026, down 5.56% on a QoQ basis from $14.5 billion in Q1 2026, and down 16.21% year-over-year from $16.3 billion in Q2 2025.

Analysis

Viatris (VTRS) Intangibles (2019 - 2026) Analysis & Trends

Viatris has reported Intangibles for 8 years, with the latest figure at $13.7 billion in Q2 2026.

  • On a quarterly basis, Intangibles fell 16.21% year-over-year to $13.7 billion in Q2 2026; TTM through Jun 2026 was $13.7 billion, a 16.21% decrease from a year earlier, with the FY2025 full-year figure at $15.1 billion, down 11.53% from the prior year.
  • Intangibles was $13.7 billion for Q2 2026 at Viatris, down from $14.5 billion in the prior quarter.
  • The five-year high for Intangibles was $25.3 billion in Q1 2022, with the low at $13.7 billion in Q2 2026.
  • Average Intangibles over 5 years is $19.2 billion, with a median of $18.8 billion recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Intangibles fell 7.53% in 2023, then declined 16.6% in 2024.
  • Over 5 years, Intangibles stood at $22.6 billion in 2022, then dropped by 15.15% to $19.2 billion in 2023, then slipped by 11.0% to $17.1 billion in 2024, then retreated by 11.53% to $15.1 billion in 2025, then slipped by 9.44% to $13.7 billion in 2026.
  • The last three Intangibles figures came in at $13.7 billion (Q2 2026), $14.5 billion (Q1 2026), and $15.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 3.45 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 13.68 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 1.09 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 587.83 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 4.18 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 142.48 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 449.86 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 29.23 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 5.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.68 Bn
Mar 31, 2026 14.48 Bn
Dec 31, 2025 15.10 Bn
Sep 30, 2025 15.72 Bn
Jun 30, 2025 16.32 Bn
Mar 31, 2025 16.66 Bn
Dec 31, 2024 17.07 Bn
Sep 30, 2024 17.98 Bn
Jun 30, 2024 18.42 Bn
Mar 31, 2024 19.13 Bn
Dec 31, 2023 19.18 Bn
Sep 30, 2023 21.28 Bn
Jun 30, 2023 22.08 Bn
Mar 31, 2023 22.70 Bn
Dec 31, 2022 22.61 Bn
Sep 30, 2022 23.01 Bn
Jun 30, 2022 24.10 Bn
Mar 31, 2022 25.25 Bn
Dec 31, 2021 26.13 Bn
Sep 30, 2021 26.99 Bn